ADGRF1 and metabolic dysfunction-associated steatotic liver disease: By HFD-induced NAFLD mouse model (Nakamura and Terauchi, 2013), it is also shown that the repression of hepatic Adgrf1 expression is a potential protective mechanism of preventing overaccumulation of lipid in liver.